Tirzepatide (Mounjaro/Zepbound) Clinics in Chicago, Illinois

38 Chicago, Illinois clinic listings include Tirzepatide (Mounjaro/Zepbound) in their listed services. A listing tells you where to ask first; prescribing is the clinician's decision after an evaluation. 1 of these listings say they accept insurance, which covers the visit and does not confirm medication coverage.

Across the 8 of 38 Chicago listings that publish a price, Tirzepatide (Mounjaro/Zepbound) programs average $374 to $849 per month. The rest do not list one. Prices depend on dosage, whether you use branded or compounded versions, and your insurance coverage.

22 of the 38 Chicago listings that name tirzepatide also list telehealth. Illinois allows telehealth prescribing by licensed providers. GLP-1 medications can be prescribed via video consultation with a licensed Illinois physician, NP, or PA. Whether a given clinic can complete your consultation by video is a question for that clinic.

No. Illinois Medicaid does not currently cover GLP-1 weight loss medications. Patients without commercial insurance coverage may want to explore compounded versions or manufacturer savings programs to reduce costs.

1 tirzepatide clinics in Chicago list that they accept insurance. Some list billing plans such as Blue Cross Blue Shield, Aetna, Cigna. Listing a plan means a clinic may bill it for visits; it does not confirm tirzepatide itself is covered. Coverage typically requires prior authorization and may depend on BMI or comorbidity criteria. Verify benefits with the clinic and your insurer.

Yes. Mounjaro and Zepbound (brand names for tirzepatide) are FDA-approved for weight management. Your provider will determine the right dosage based on your health history and goals.